1. Home
  2. SHBI vs YDES Comparison

SHBI vs YDES Comparison

Compare SHBI & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shore Bancshares Inc

SHBI

Shore Bancshares Inc

N/A

Current Price

$21.72

Market Cap

676.5M

Sector

Finance

ML Signal

N/A

YDES

YD Bio Limited Ordinary Shares

N/A

Current Price

$2.95

Market Cap

543.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
SHBI
YDES
Founded
1876
2013
Country
United States
Taiwan
Employees
N/A
N/A
Industry
Major Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
676.5M
543.0M
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
SHBI
YDES
Price
$21.72
$2.95
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$19.17
N/A
AVG Volume (30 Days)
157.9K
10.6K
Earning Date
04-23-2026
05-12-2026
Dividend Yield
2.51%
N/A
EPS Growth
34.85
N/A
EPS
0.51
N/A
Revenue
$20,853,000.00
N/A
Revenue This Year
$8.97
N/A
Revenue Next Year
$6.26
N/A
P/E Ratio
$41.92
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.35
$2.88
52 Week High
$21.53
$25.00

Technical Indicators

Market Signals
Indicator
SHBI
YDES
Relative Strength Index (RSI) 68.31 26.98
Support Level $17.18 $2.88
Resistance Level N/A $5.36
Average True Range (ATR) 0.60 0.41
MACD 0.12 -0.06
Stochastic Oscillator 91.13 3.74

Price Performance

Historical Comparison
SHBI
YDES

About SHBI Shore Bancshares Inc

Shore Bancshares Inc is a financial holding company based in the United States. Through its subsidiaries, it provides consumer and commercial banking products and services, as well as secondary mortgage lending, trust, wealth management, and financial planning services. The group caters to both business and individual clients, offering checking, savings, certificates of deposit, and overnight investment sweep accounts; commercial lending services, including secured and unsecured loans, working capital loans, lines of credit, etc; and safe deposit boxes, debit cards, telephone banking, and other financial products and services.

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

Share on Social Networks: